2,458 material Form 8-K filings that 2,075 companies we cover made with the SEC in November 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 1,081 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Parabolic Technologies, Inc. (Nasdaq: PARA) closed a $13.5 million underwritten public offering on November 5, 2026, selling units that each include one share or a pre-funded warrant plus two warrants. The filing says net proceeds were approximately $5.512 million, and the warrants include exercise-price resets that can increase the number of shares issuable, which could dilute existing shareholders.
Gross proceeds of about $13.5 million from 4,963,235 units priced at $2.72 each, with net proceeds of about $5.512 million after offering expenses
Each unit includes two warrants with an initial exercise price of $6.80 per share, for up to 9,926,470 warrant shares
Warrants reset on the fifth and tenth trading days after issuance to the lower of the then-current exercise price and 80% of the lowest VWAP in the measurement period, subject to floor prices, and holders keep additional shares from resets
Aegis Capital Corp. holds a 45-day over-allotment option, and the Underwriter exercised it for 360,000 warrants on November 5, 2026
Avalanche Treasury Corp (AVAT) reported preliminary, unaudited third-quarter 2026 net income of approximately $54.6 million, or $1.53 per diluted share, with about $60 million from market-driven changes in the value of its AVAX holdings and realized losses. It also repurchased about 8% of its Class A shares at an average price of $1.14 and repaid its FalconX loan in full, and the full third-quarter results are due in November 2026.
Preliminary Q3 2026 net income of approximately $54.6 million, or $1.53 per diluted share; approximately $60 million of gains from market-driven changes in AVAX value and realized losses
Repurchased 2,889,440 Class A shares at an average of $1.14 per share, about $3.3 million in total, roughly 8% of Class A shares outstanding as of August 24, 2026
Held 13.31 million AVAX tokens as of September 30, 2026, with about 60% unlocked; about 91% was staked in September 2026
Conference call on November 19, 2026 at 4:00 p.m. ET to discuss third-quarter results
Annovis Bio agreed on November 5, 2026 to sell 19,000,000 shares of common stock (or pre-funded warrants in lieu of shares) with accompanying warrants, with expected gross proceeds of approximately $21.0 million before underwriting discounts and expenses. The offering adds shares and warrants that could dilute existing shareholders, while the company plans to use the proceeds for clinical development of buntanetap and working capital.
Offering of 19,000,000 shares plus pre-funded warrants for up to 2,000,000 shares, with accompanying warrants for up to 21,000,000 shares, priced at $1.00 per share and accompanying warrant
Accompanying warrants are exercisable at $1.00 per share and expire five years after issuance
One of the company's directors is buying 5,000,000 shares and accompanying warrants for $5,000,000
Offering is expected to close on or about November 6, 2026, with Canaccord Genuity LLC as underwriter
Algorhythm Holdings' CEO and Chairman Andrew Thompson resigned effective immediately, with the board stating no disagreement over operations, policies or practices. Director Gregory D. Smith was appointed to both roles on November 2, 2026, under a CEO agreement with a base salary of $375,000 rising to $480,000 on performance conditions.
Andrew Thompson resigned as CEO and Chairman, accepted by the board on October 30, 2026.
Gregory D. Smith, age 67 and a board member since September 2026, became CEO and Chairman on November 2, 2026.
Smith's agreement provides a 2,119,542-share restricted stock award, with 1,059,771 shares vesting immediately and 1,059,771 vesting on the first anniversary of the effective date.
Severance equals two times base salary plus maximum annual bonus; the filing reports 40,848,979 common shares outstanding as of November 4, 2026.
Datavault AI's board removed Nathaniel Bradley as Chief Executive Officer and President and terminated his employment, effective immediately, on November 1, 2026. The action was approved by all directors except Mr. Bradley, who voted against it, and he continues to serve as a board member. The filing does not name a successor or an interim leader, leaving the company's top executive role open as of the filing date.
Removal effective November 1, 2026, with employment terminated immediately
Board action approved by all directors other than Mr. Bradley, who voted against it
Mr. Bradley remains a board member until the next annual meeting or earlier resignation or removal
Copley Acquisition Corp's shareholders approved extending the deadline to complete a business combination from November 2, 2026 to November 2, 2027, with up to 12 monthly extensions. Holders of 12,889,720 Class A shares redeemed for about $137.1 million, leaving about $46.2 million in the trust account, which matters to shareholders because it reduces the cash backing the remaining shares.
Holders of 12,889,720 Class A shares redeemed at about $10.63 per share, an aggregate of about $137,119,390.16
About $46,241,913.77 remains in the Trust Account and 4,550,280 Class A ordinary shares remain outstanding
Each monthly extension requires a $200,000 deposit into the Trust Account; the first extension runs to December 2, 2026
Sponsor issued an unsecured, non-interest-bearing $2,400,000 promissory note; the vote was 14,428,832 for and 7,101,879 against
ANI Pharmaceuticals entered a 364-day senior bridge credit facility of up to $676 million with JPMorgan Chase Bank, N.A. as administrative agent. The facility will be used to finance its recommended public cash offer for Egetis Therapeutics shares, convertible loan and warrants, valued at about SEK 5.6 billion, or approximately $559.9 million, and to refinance ANI's existing term loans and some Egetis debt, which adds significant borrowing and secured obligations for ANI shareholders.
Facility allows borrowings up to $676 million and matures 364 days after initial funding
Initial margin of 1.75% for ABR loans and 2.75% for adjusted term SOFR loans
Offer price is SEK 11.25 per Egetis share; total value about SEK 5.6 billion, or $559.9 million
Completion requires holders of at least 90% of Egetis shares (fully diluted) to tender and regulatory clearances; undertakings covering 42.2% of shares expire if the offer is not declared unconditional by March 31, 2027
Change Agents Corporation appointed Chief Strategy Officer Luisa Ingargiola as principal executive officer on November 4, 2026, until it names a new Chief Executive Officer, with no added compensation. The company also issued a $250,000 promissory note to Harllon Holdings LLC with a $75,000 original issue discount, requiring repayment of $325,000 on January 1, 2027, and agreed to issue 150,000 shares to consultants for services.
Luisa Ingargiola, Chief Strategy Officer since June 3, 2026, was appointed principal executive officer on November 4, 2026, and will receive no additional compensation for the role.
Promissory note issued November 4, 2026 to Harllon Holdings LLC: $250,000 principal, $75,000 original issue discount, $325,000 due January 1, 2027.
The note may be prepaid on December 1, 2026 for $312,000.
150,000 shares of common stock agreed to be issued to consultants for services, under the Section 4(a)(2) registration exemption.
Brighthouse Financial reported third quarter 2026 net income available to shareholders of $302 million, or $5.21 per diluted share, down from $453 million, or $7.89 per share, a year earlier. Adjusted earnings fell to $527 million, or $9.12 per share, from $970 million, or $16.87 per share, though the company said its annual actuarial review added $314 million of net favorable notable items. The company also said regulatory approvals for the pending $70.00 per share Aquarian Capital acquisition are not expected before the December 6, 2026 Outside Date, and the parties are discussing an extension.
Net income available to shareholders was $302 million, or $5.21 per diluted share, versus $453 million, or $7.89 per share, in the third quarter of 2025.
Adjusted earnings, less notable items, were $213 million, or $3.68 per diluted share, versus $261 million, or $4.54 per share, a year earlier.
Annuity sales were $2.4 billion, including $2.1 billion of Shield Level Annuities, with annuity sales down 12% quarter-over-quarter.
The merger agreement's Outside Date is December 6, 2026; the company and Aquarian Capital are discussing an extension, with no assurance of agreement.
Ready Capital reported a third-quarter 2026 GAAP net loss of $62.2 million, or $(0.40) per share, compared with a net loss of $16.7 million, or $(0.13) per share, a year earlier. Distributable loss was $(0.53) per share, and the company declared $0.01 per common share in dividends, down from $0.125 a year earlier, which matters to shareholders because it reflects weaker earnings and a much smaller dividend.
Q3 2026 GAAP loss per common share of $(0.40), versus $(0.13) in Q3 2025; nine-month loss per share of $(2.27)
Distributable loss per common share of $(0.53); before realized losses, $(0.21)
Dividends declared per common share of $0.01 in Q3 2026, versus $0.125 in Q3 2025
Book value of $6.44 per common share as of September 30, 2026; cash of $157 million and total leverage of 2.8x
Diodes reported third quarter 2026 revenue of $532.6 million, up 35.8% from a year earlier, with GAAP net income of $43.7 million, or $0.95 per diluted share, versus $0.31 a year earlier. The company expects fourth quarter revenue of about $550 million, plus or minus 3%, and non-GAAP adjusted EPS of $1.35, plus or minus $0.10. The results are preliminary and unaudited and remain subject to revision until the Form 10-Q is filed.
Q3 2026 revenue $532.6 million, up 35.8% from $392.2 million in Q3 2025
GAAP EPS $0.95 per diluted share vs $0.31 in Q3 2025; non-GAAP EPS $1.18 vs $0.37
Q4 2026 outlook: revenue about $550 million (plus or minus 3%); non-GAAP EPS $1.35 (plus or minus $0.10)
Private placement of 0.00% Convertible Senior Notes due 2031 totaling $375 million
PLAYSTUDIOS reported third-quarter 2026 revenue of $48.9 million, down from $57.6 million a year earlier, and a net loss of $11.0 million, up from $9.1 million. The company discontinued two products, Tetris Block Party and The Win Zone, and recorded $6.7 million in non-cash impairment charges plus a $9.2 million goodwill impairment. It is not providing formal financial guidance, which leaves shareholders without a forward outlook.
Q3 2026 revenue was $48.9 million versus $57.6 million in Q3 2025; direct-to-consumer revenue rose 108% to $16.0 million.
Net loss was $11.0 million versus $9.1 million; Consolidated AEBITDA rose to $10.0 million from $7.2 million.
Goodwill impairment of $9.2 million and a $6.7 million non-cash impairment charge tied to the discontinued products.
No formal financial guidance was provided; restructuring annualized savings range was raised to $37.0 million to $39.0 million, with $44.6 million left on the share repurchase authorization.
Inspired Entertainment reported third-quarter 2026 revenue of $61.4 million, down 29% from $86.2 million a year earlier, mainly reflecting the November 2025 divestiture of its UK Holiday Parks business; like-for-like revenue rose about 4%. The company also lowered its full-year 2026 Adjusted EBITDA target to $109 million to $112 million from $112 million to $118 million, primarily because Brazil suspended regulated online betting and gaming, a business representing about 5% of revenue.
Q3 2026 revenue was $61.4 million versus $86.2 million a year earlier; like-for-like revenue rose about 4%.
Q3 Adjusted EBITDA was $28.2 million versus $32.3 million, with a record 46% margin versus 37%.
Q3 net loss narrowed to $0.1 million from $1.9 million a year earlier.
FY2026 Adjusted EBITDA outlook is now $109 million to $112 million, down from $112 million to $118 million.
Iovance furnished an updated corporate presentation on November 5, 2026, for use at healthcare conferences and with analysts and stockholders. The presentation gives full-year 2026 revenue guidance of $410 million to $420 million, and its footnote states the midpoint is $55 million, or about 15%, above the previous range of $350 million to $370 million.
Full-year 2026 revenue guidance is $410 million to $420 million, up from a previous range of $350 million to $370 million.
The presentation cites about 80% year-over-year and about 22% quarter-over-quarter revenue growth in third-quarter 2026.
Cash, cash equivalents, short-term investments and restricted cash were about $382 million as of September 30, 2026, with runway stated as well into 2029.
Margin from cost of sales, excluding depreciation and amortization, was about 60% in third-quarter 2026 and 54% year to date.
Strawberry Fields REIT reported third-quarter 2026 results that were pulled down by a $24.6 million foreign currency transaction loss tied to the retirement of Bond Series A, C and D. Net loss was $14.8 million and FFO was negative $3.6 million, compared with net income of $8.9 million and FFO of $20.7 million a year earlier. AFFO, which excludes that loss, rose to $18.8 million, or $0.34 per share, from $18.1 million, or $0.33 per share.
Q3 2026 net loss of $14.8 million vs. net income of $8.9 million in Q3 2025
Q3 2026 FFO of negative $3.6 million ($0.65 per share loss) vs. $20.7 million ($0.37 per share) a year earlier
Q3 2026 AFFO of $18.8 million ($0.34 per share), up from $18.1 million ($0.33 per share)
Subsequent to quarter end on November 1, 2026, the company agreed to buy a 99-bed skilled nursing facility in Angola, Indiana for $15 million
CVD Equipment reported third-quarter 2026 revenue of $1.6 million, down 72.1% from a year earlier, and a loss from continuing operations of $2.1 million, or $0.30 per share. The company will no longer pursue new system orders, has cut its workforce further, and has engaged CBRE to sell its Central Islip and Saugerties, New York properties, which matters to shareholders because the core equipment business is winding down while the company holds $23.5 million of cash and no debt.
Q3 2026 revenue was $1.6 million versus $5.7 million in Q3 2025; gross margin was 9.2% versus 32.0%.
Net loss from continuing operations was $2.1 million, or $0.30 per share, including an $0.8 million restructuring charge; income from discontinued operations was $0.6 million.
Cash and cash equivalents were $23.5 million at September 30, 2026, with no outstanding debt.
CBRE, Inc. has been engaged to market the Central Islip and Saugerties, New York properties for sale.
iSpecimen completed on November 2, 2026, its acquisition of AI software and related assets from Foldlab AI Ltd. for an aggregate price of $4.5 million, paid in cash, milestone payments and stock. The issuance of 2,907,977 shares to Foldlab on November 5, 2026 gives Foldlab approximately 53.6% of the outstanding common stock, a change in control, which means existing shareholders' ownership is substantially diluted.
Purchase price of $4.5 million: $750,000 cash at closing, two $625,000 milestone payments tied to delivery and acceptance, and $2.5 million in stock.
Stock consideration of 2,907,977 shares, based on a $0.8597 volume-weighted average price, issued to Foldlab on November 5, 2026.
Foldlab holds approximately 53.6% of outstanding shares; Zhengkang (Jacob) Shao is its sole director and shareholder.
Shares are subject to a five-year lock-up with no leak-out; stockholders approved the issuance at a special meeting on October 9, 2026.
PodcastOne said it expects record first-half revenue of $31.5 million and Adjusted EBITDA of $3.0 million, up 76% year over year, for the six months ended September 30, 2026. Second-quarter revenue is expected to be $15.2 million with Adjusted EBITDA of $1.4 million. These figures are preliminary, unaudited and subject to change, and the company's board has formed a special committee to evaluate inbound strategic interest, which may or may not lead to a transaction.
Expected first-half revenue of $31.5 million and Adjusted EBITDA of $3.0 million, up 76% year over year
Expected second-quarter revenue of $15.2 million and Adjusted EBITDA of $1.4 million
Special committee of independent directors formed after inbound interest from multiple strategic parties, first announced October 28; company intends to retain a financial advisor
Figures are preliminary and unaudited, not reviewed by MGO; no GAAP net income reconciliation was provided
NextEra Energy filed unaudited pro forma combined financial information and Dominion Energy's financial statements for the pending merger, which was agreed on May 15, 2026. The filing estimates total merger consideration at $62.1 billion, based on NEE's $83.71 closing price on October 30, 2026, and shows lower pro forma per-share earnings than NEE's historical figures. The deal still requires several regulatory approvals and other closing conditions, and the company says the pro forma figures are illustrative only.
Each Dominion Energy share converts into $360 million in aggregate cash, plus 0.8138 NEE shares, pro rata
Estimated merger consideration is $62.1 billion, based on about 738 million NEE shares at $83.71
Pro forma nine-month 2026 basic EPS is $4.16, versus NEE's historical $4.84
Closing requires HSR clearance and approvals from FERC, NRC, and the Virginia, North Carolina and South Carolina regulators
Meta Platforms completed a $15.0 billion offering of five U.S. dollar senior note series maturing from 2031 to 2056, with fixed rates from 5.850% to 7.500%. Underwriters also exercised in full their option to buy 6,000,000 additional Class A common shares from an offering priced in late October 2026, with forward sale agreements covering those shares. The filing does not state how the proceeds will be used, so the added debt and share sales are the main points for shareholders to weigh.
Five senior note series: $3.25 billion due 2031, $3.25 billion due 2033, $4.0 billion due 2036, $1.75 billion due 2046 and $2.75 billion due 2056
Notes were issued under an indenture dated August 9, 2022 with U.S. Bank Trust Company, National Association, as trustee, and a sixth supplemental indenture dated November 5, 2026
Underwriters exercised their option in full on November 4, 2026 for 6,000,000 additional Class A common shares, with additional forward sale agreements on similar terms
Underwriting agreement dated November 3, 2026 with Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC as representatives
Helios Technologies reported third-quarter 2026 net sales of $230 million, up 4% from the prior-year period, and GAAP diluted EPS of $0.53, up 71% from $0.31. The company raised its full-year 2026 sales outlook to $895 million to $902 million from $880 million to $900 million, while narrowing its adjusted EBITDA margin and adjusted diluted EPS ranges.
Q3 2026 net sales were $229.7 million, up 4%; the company cited 13% growth on a pro forma basis
Q3 GAAP diluted EPS was $0.53 versus $0.31; adjusted diluted EPS was $0.80, up 11%
FY2026 sales outlook raised to $895 million to $902 million; adjusted diluted EPS range narrowed to $3.08 to $3.15
Q4 2026 outlook: sales of $205 million to $212 million and adjusted diluted EPS of $0.60 to $0.67
Starling Oncology reported third-quarter 2026 revenue of $169.8 million, up 24.3% from a year earlier, and a net loss of $15.7 million, narrower than $16.5 million a year earlier. The company narrowed its full-year 2026 Adjusted EBITDA guidance and lowered the top end of its revenue and free cash flow ranges, so the outlook is mixed for shareholders.
Q3 2026 revenue was $169.8 million, up from $136.6 million; net loss was $15.7 million versus $16.5 million, or $(0.13) per share versus $(0.14).
Adjusted EBITDA, a non-GAAP measure, was $3.4 million versus $(3.5) million a year earlier.
2026 revenue guidance is now $650 million to $660 million, down from $650 million to $670 million; free cash flow guidance is now $5 million to $10 million, down from $5 million to $15 million.
2026 Adjusted EBITDA guidance narrowed to $4 million to $6 million from $2 million to $7 million; gross profit guidance is now $107 million to $110 million, up at the low end from $105 million.
Axon Enterprise announced an incremental minority investment of about $1.2 billion in drone maker Skydio, which it expects will raise Axon's fully diluted ownership from about 15% to about 37%. The primary purchase closed on November 5, 2026, and the remaining transactions are expected to close in the fourth quarter of 2026 and first quarter of 2027. The deal adds a large cash outlay and share issuance for Axon, and Axon also becomes Skydio's exclusive public safety distributor in the U.S. and Canada.
Primary purchase closed November 5, 2026: 25,000,000 Series G preferred shares at $10.19617 per share, for about $254.9 million in aggregate.
Total investment is about $1.2 billion, with about $720 million (approximately 60%) expected in cash and the remainder in Axon common stock.
Axon stock issued for the investment is capped at 19.99% of shares outstanding before the primary closing.
Tender offer to begin within ten business days of the primary closing; the Committed Secondary is expected to close in the first quarter of 2027.
Athene Holding furnished its third-quarter 2026 financial supplement, showing a GAAP net loss available to common stockholder of $1,158 million, compared with net income of $1,223 million a year earlier. Spread related earnings, the company's management measure, fell 3% to $844 million, but rose 7% to $909 million excluding notable items, and the filing says the GAAP loss was tied to large investment and market risk benefit swings. Shareholders face a larger GAAP loss and lower stockholders' equity, while the underlying spread measure was mixed.
GAAP net loss available to Athene common stockholder of $1,158 million in 3Q'26, versus net income of $1,223 million in 3Q'25
Spread related earnings of $844 million, down 3% year over year; excluding notable items, $909 million, up 7%
Total revenues of $3,065 million versus $7,998 million a year earlier, with investment related losses of $3,418 million
Total Athene Holding stockholders' equity was $13,413 million at September 30, 2026, down from $20,492 million at December 31, 2025
Pangaea Logistics Solutions reported third-quarter 2026 results, with GAAP net income attributable to the company of $38.3 million, or $0.59 per share, up from $12.2 million, or $0.19 per share, a year earlier. Total revenue was $219.1 million, and Adjusted EBITDA rose 81.3% to $52.4 million, which matters to shareholders because it shows a large year-over-year gain in earnings and cash generation. The board also declared a $0.10 quarterly dividend.
GAAP net income attributable to Pangaea of $38.3 million, or $0.59 per share, versus $12.2 million, or $0.19 per share, in Q3 2025
Total revenue of $219.1 million versus $168.7 million in Q3 2025; Adjusted EBITDA of $52.4 million, a 23.9% margin versus 17.1%
Average TCE rate of $20,414 per day versus $15,559 per day a year earlier; the company reported cash and equivalents of $144.9 million at September 30, 2026
Quarterly dividend of $0.10 per share, payable December 15, 2026, to holders of record on December 1, 2026
Sunrise Realty Trust (SUNS) completed its merger with Southern Realty Trust on November 5, 2026. Southern Realty Trust stockholders received 1.45 SUNS shares and $0.05 in cash from SUNS Manager for each share they held, and SUNS issued 8,464,975 shares, bringing shares outstanding to 21,980,826. The company also amended its management agreement, cutting the incentive fee and hurdle rate and reducing the base management fee, which the filing says benefits all SUNS stockholders, while former Southern Realty Trust holders now own about 38.5% of the combined company.
Merger closed November 5, 2026; each Southern Realty Trust share converted into 1.45 SUNS shares plus $0.05 in cash from SUNS Manager
SUNS issued 8,464,975 shares, resulting in 21,980,826 shares outstanding; former Southern Realty Trust stockholders own about 38.5%
Incentive fee reduced from 20% to 17.5% and hurdle rate from 8.0% to 7.0%; base management fee cut by $250,000 per quarter for four quarters, or $1.0 million in total
Pro forma as of June 30, 2026, the combined company had about $534 million of total assets and about $285 million of book value
Friedman Industries reported record second-quarter results for the period ended September 30, 2026, with net earnings of $15.6 million on net sales of $286.8 million, versus $2.2 million and $152.4 million a year earlier. The company also recorded a $14.6 million hedging charge in the quarter, of which $9.8 million is unrealized, a charge close in size to the quarter's net earnings.
Net earnings of $15.6 million ($2.19 diluted EPS) vs. $2.2 million ($0.32) in the prior-year quarter
Net sales of $286.8 million, up from $152.4 million; sales volume of about 219,500 tons, up 23%
$14.6 million hedging charge in the quarter, including $9.8 million unrealized on open metal positions
Management expects third-quarter sales volume consistent with seasonal trends and sequential margin improvement
CVR Energy agreed to sell 10,515,248 common shares at $47.55 each, with net proceeds of about $490.0 million before offering expenses, closing November 5, 2026. The company plans to use the proceeds with cash on hand and other financing to fund its acquisition of the St. Paul Park and Mandan refineries from Marathon Petroleum subsidiaries, redeem its 5.750% Senior Notes due 2028, and pay related fees.
Offering: 10,515,248 shares at $47.55 per share, with a 30-day option for up to 1,577,287 additional shares
Net proceeds of approximately $490.0 million; offering closed November 5, 2026
Proceeds to fund the St. Paul Park and Mandan refinery acquisition and redeem 2028 Notes; if the acquisition does not close, proceeds go to general corporate purposes
Selling stockholder IEP Energy Holding LLC is not included in the priced offering; the company receives no proceeds from its shares
Krispy Kreme's board approved an amendment to CEO Joshua Charlesworth's employment agreement on October 30, 2026. The change raises his annual cash target bonus from 100% to 150% of base salary, effective November 1, 2026, and increases his annual restricted stock unit grant from $1,000,000 to $2,500,000, starting with the 2027 grant. The filing does not state a financial reason for the change, but it raises the potential pay of the company's top executive.
Target annual cash bonus rises from 100% to 150% of base salary, effective November 1, 2026.
Annual restricted stock unit grant increases from $1,000,000 to $2,500,000, beginning with the 2027 annual grant.
Changes were approved by the Board of Directors on October 30, 2026 and disclosed in a filing dated November 5, 2026.
MSC Income Fund reported third quarter 2026 total investment income of $35.5 million, up $0.2 million from a year earlier, while net investment income fell 13% to $14.4 million, or $0.32 per share. Net increase in net assets from operations dropped 32% to $18.1 million, and net asset value rose to $16.56 per share from $16.51 at June 30, 2026, and $15.85 at December 31, 2025. Nick Meserve is set to become CEO effective November 9, 2026, as previously announced in June.
Net investment income was $14.4 million, or $0.32 per share, versus $16.6 million, or $0.35 per share, in Q3 2025.
Total investment income was $35.5 million, compared with $35.4 million in Q3 2025.
Net asset value was $16.56 per share as of September 30, 2026, up from $16.51 at June 30, 2026.
Nick Meserve will transition to CEO effective November 9, 2026, with Dwayne L. Hyzak continuing as Executive Chairman.
CBL reported third-quarter 2026 results and raised its full-year 2026 FFO, as adjusted, guidance to $7.34 to $7.44 per share. Total revenues rose to $148.7 million from $139.3 million, but GAAP net income per share fell to $0.37 from $2.38, when the prior-year quarter included large property sale and deconsolidation gains. For shareholders, the results show stronger operating measures and a new $25.0 million buyback authorization, alongside lower reported earnings.
Q3 2026 total revenues were $148.7 million versus $139.3 million a year earlier; same-center NOI rose 3.8%.
Net income attributable to common shareholders was $0.37 per share versus $2.38; FFO was $1.05 per share versus $2.17.
2026 FFO, as adjusted, guidance was raised to $7.34 to $7.44 per share; same-center NOI guidance is 0.75% to 2.25%.
On November 4, 2026, the Board authorized repurchases of up to $25.0 million of common stock; the $0.625 per share Q4 dividend is payable December 31, 2026.
Concentra Group Holdings Parent, Inc. reported its third quarter 2026 financial results, highlighting an 8.6% increase in revenue to $622.1 million and a 36.0% increase in net income to $67.8 million compared to the same period in 2025. Driven by this performance, the company raised its full-year 2026 financial guidance, declared a cash dividend of $0.0625 per share, and authorized a new $250 million share repurchase program.
Revenue for the third quarter of 2026 reached $622.1 million, up 8.6% year over year.
Net income for the quarter rose 36.0% to $67.8 million, with basic and diluted earnings per share at $0.52.
The board of directors declared a cash dividend of $0.0625 per share, payable on or about December 4, 2026.
A new share repurchase program was authorized to buy back up to $250 million of outstanding common stock.
Spruce Power subsidiaries amended their KeyBank credit agreement on October 30, 2026, changing covenant terms tied to a refinancing and requiring new deliverables by November 9, 2026. The same day, subsidiaries signed a non-binding term sheet with a financial institution for a funded debt facility to refinance the SP1, SP2 and SP3 facilities, but the filing states the terms remain indicative and subject to change. The filing also warns that failure to complete a refinancing by January 30, 2027 could have serious consequences, including going-concern risk.
October 30, 2026: subsidiaries amended the Second KeyBank Credit Agreement and entered a term sheet with a financial institution
By November 9, 2026: company must deliver a long-term financial model assuming refinancing of Senior Loan Obligations, and SP4 HoldCo and SP5 HoldCo must execute agreements for the SP4/SP5 Collateral Addition covenant
The proposed Refinancing Facility would refinance the SP1, SP2 and SP3 facilities; the filing cites a January 30, 2027 refinancing risk date
Ameren Corporation announced its third quarter 2026 financial results, reporting a GAAP diluted EPS of $2.42 compared to $2.35 for the same period in 2025. Driven by strong year-to-date performance and infrastructure investments, the company raised its 2026 earnings guidance range and established its 2027 outlook.
Third quarter 2026 GAAP diluted EPS was $2.42 versus $2.35 in the third quarter of 2025.
Raised 2026 earnings guidance range to $5.35 to $5.55 per diluted share.
Established 2027 earnings guidance range of $5.70 to $5.90 per diluted share.
Planned infrastructure investments of $38.1 billion to support projected rate base growth through 2031.
Mettler-Toledo International Inc. reported third quarter 2026 net sales of $1.094 billion, representing a 6% increase compared to the prior-year period. Diluted earnings per share rose to $12.29 from $10.57, while adjusted EPS grew 13% to $12.57, driven by improving market demand and solid execution. Management also raised its full-year 2026 adjusted EPS guidance range to $47.70 to $47.90.
Reported net sales for the third quarter of 2026 increased 6% to $1.094 billion.
Diluted earnings per share were $12.29, compared with $10.57 in the third quarter of 2025.
Adjusted diluted EPS increased 13% to $12.57 from $11.15 in the prior-year period.
Full-year 2026 adjusted EPS is forecast to be between $47.70 and $47.90.
Hyster-Yale reported third-quarter 2026 revenue of $827.4 million, down 15% from a year earlier but up 2% from the prior quarter, with a net loss of $14.9 million compared with a $2.3 million loss in Q3 2025. The company expects substantially stronger Q4 2026 results, with adjusted net income returning to positive, and launched cost-reduction programs targeting at least $100 million of annual savings at maturity, with implementation costs of at least $50 million.
Q3 2026 revenue was $827.4 million, down from $979.1 million in Q3 2025 and up from $812.9 million in Q2 2026.
Net loss was $14.9 million, or $0.83 per diluted share, versus a $2.3 million loss in Q3 2025; adjusted diluted loss was $0.77 per share.
Lift Truck bookings rose 45% year over year to $550 million, and unit backlog reached $1.6 billion.
New programs target at least $100 million of annual cost savings at maturity in 2029, with implementation costs of at least $50 million; 2026 capital expenditures are expected at $50 million to $60 million.
Mercer International reported third-quarter 2026 revenue of $440.7 million and a net loss of $59.2 million, or $0.88 per share, narrower than the $80.8 million loss a year earlier. The company also said it signed restructuring support agreements on November 2, 2026, and expects to commence prepackaged Chapter 11 cases to exchange about $1.1 billion of senior notes for equity, which would substantially change its capital structure and shareholder position.
Restructuring support agreements signed November 2, 2026 with holders of more than 87% of senior notes and a majority of common shares
About $1.1 billion of senior notes to be exchanged for equity, with $400 million of new capital through a fully backstopped rights offering
Q3 2026 Operating EBITDA was negative $2.9 million, compared with negative $28.1 million in Q3 2025; revenue fell about 4% to $440.7 million
Cash and cash equivalents were $71.0 million and total shareholders' equity was a deficit of $158.2 million as of September 30, 2026
Pacira BioSciences said Viatris has commenced a tender offer to buy all Pacira shares for $36.50 each in cash, under a merger agreement signed October 8, 2026, with a second-step merger planned after the offer closes. Pacira will not issue its Q3 2026 earnings release or hold a call, and it has withdrawn its 2026 financial guidance, so shareholders will have no updated company financial outlook during the pending deal.
Viatris, through subsidiary Peach Purchaser Sub Inc., commenced the tender offer on October 30, 2026 at $36.50 per share in cash
Merger agreement with Viatris was entered into on October 8, 2026; completion depends on conditions including a Minimum Condition
Pacira will not release Q3 results for the quarter ended September 30, 2026, and has withdrawn its previously issued 2026 guidance
Cryoport reported third-quarter 2026 revenue of $50.2 million, up 14% from a year earlier, and raised its full-year 2026 revenue guidance to $197 million to $199 million. The company still posted a wider net loss attributable to common stockholders of $12.9 million, or $0.25 per share, compared with a $8.9 million loss, or $0.18 per share, in the prior-year quarter.
Q3 2026 total revenue was $50.2 million, up 14% year over year; Life Sciences Services rose 18% to $28.6 million.
Full-year 2026 revenue guidance was raised to $197 million to $199 million.
Q3 2026 net loss attributable to common stockholders was $12.9 million, or $0.25 per share, versus $8.9 million, or $0.18 per share, in Q3 2025.
Adjusted EBITDA from continuing operations was $1.1 million for Q3 2026, compared with a negative $0.6 million a year earlier.
Camden Property Trust announced its third quarter 2026 operating results, reporting a diluted EPS of $8.71 primarily driven by a gain on the sale of its California portfolio. The company updated its full-year 2026 earnings guidance and adjusted its same-property growth forecasts.
Diluted EPS for 3Q26 was $8.71, compared to $1.00 in 3Q25.
Core FFO per diluted share for 3Q26 was $1.71, compared to $1.70 in 3Q25.
The company sold its California portfolio for approximately $1.6 billion, recognizing a gain of about $1.0 billion.
Full-year 2026 diluted EPS guidance was revised to a range of $9.42 to $9.46.
Horizon Technology Finance reported third quarter 2026 net investment income of $12.3 million, or $0.19 per basic share, down from $14.0 million, or $0.32 per share, a year earlier. The company posted a net decrease in net assets from operations of $28.2 million, or $0.43 per share, compared with a net increase of $30.7 million in the prior-year quarter, and net asset value fell to $5.56 per share from $7.12 a year earlier.
Net investment income of $12.3 million ($0.19 per basic share) vs. $14.0 million ($0.32) in Q3 2025; total investment income was $24.1 million vs. $26.3 million.
Net decrease in net assets from operations of $28.2 million ($0.43 per share), including net unrealized depreciation on investments of $29.1 million.
Net asset value was $5.56 per share at September 30, 2026, vs. $7.12 at September 30, 2025 and $6.98 at December 31, 2025.
Board declared monthly distributions of $0.06 per share for January, February and March 2027, totaling $0.18 per share; Q3 distributions were $0.27 per share.
Xponential Fitness reported third quarter 2026 revenue of $62.3 million, down 21% from a year earlier, and adjusted EBITDA of $24.3 million, down 27%. The company cut its net new studio openings outlook to 124 to 130 from about 150 and narrowed its adjusted EBITDA range to $91.0 million to $94.0 million from $91.0 million to $97.0 million, which lowers the top end, while the Board continues a strategic review that may include a sale of the company.
Q3 2026 revenue was $62.3 million versus $78.8 million; net income was $4.9 million, or $0.10 per basic share, compared with a net loss of $6.7 million a year earlier.
Adjusted EBITDA was $24.3 million versus $33.5 million; North America same store sales decreased 7.5%.
2026 net new studio openings outlook is 124 to 130, versus previous guidance of approximately 150.
2026 adjusted EBITDA outlook narrowed to $91.0 million to $94.0 million from $91.0 million to $97.0 million; the strategic review, announced in April and supported by Jefferies, may result in a sale of the company.
ePlus reported second-quarter fiscal 2027 results with net sales up 9.7% to $667.9 million and GAAP diluted earnings per share up 7.6% to $1.56, and raised its full-year fiscal 2027 guidance. Services revenue fell 2.4%, and the company also declared a $0.27 quarterly dividend and announced that General Counsel Erica Stoecker will retire, with Amanda Dupree succeeding her.
Net sales rose 9.7% to $667.9 million, while services revenues fell 2.4% to $120.8 million
GAAP diluted EPS rose 7.6% to $1.56; non-GAAP diluted EPS rose 19.0% to $1.82
Guidance raised to upper single-digit growth in net sales and gross profit and low double-digit growth in adjusted EBITDA for fiscal 2027
Quarterly dividend of $0.27 per share payable December 16, 2026, to holders of record on November 24, 2026
PNC's board appointed Alexander E. C. Overstrom, currently executive vice president and head of Retail Banking, as chief financial officer effective March 1, 2027. Robert Q. Reilly, the current CFO, will become executive vice chairman on the same date, serving as a senior executive advisor to Chairman and CEO William S. Demchak. The filing does not report financial results, so it contains no direct measure of business performance.
Alexander E. C. Overstrom, 42, joined PNC in 2014 and has led Retail Banking since July 2022.
Robert Q. Reilly has been CFO since 2013 and remains in the role until March 1, 2027.
Permanent successor for PNC Retail Banking will be named in the near future.
Kingstone reported third-quarter 2026 net income of $17.6 million, or $1.19 per diluted share, compared with $10.9 million, or $0.74 per diluted share, a year earlier. The company raised and narrowed its 2026 diluted EPS guidance to $2.70 to $2.90 from $2.20 to $2.90, which matters to shareholders because it points to higher expected full-year earnings, though catastrophe losses and bond market losses affected the quarter.
Q3 2026 net income of $17.6 million, up 61.7%; diluted EPS of $1.19 versus $0.74 in Q3 2025.
Net premiums earned rose 30.2% to $62.4 million; direct premiums written rose 14.5% to $86.8 million.
2026 diluted EPS guidance raised to $2.70 to $2.90 from $2.20 to $2.90; net combined ratio outlook set at 79% to 83% from 81% to 86%.
Q3 catastrophe loss ratio was 7.5% versus 0.2% a year earlier; other comprehensive loss was $9.7 million after tax in the quarter.
Morgan Stanley Direct Lending Fund reported third-quarter 2026 net investment income of $40.3 million, or $0.48 per share, up from $38.2 million, or $0.45 per share, in the prior quarter. Net asset value fell to $18.76 per share from $19.50, and the company reported a per-share net loss of $0.32, driven by net realized and unrealized losses. The Board also approved a lower base management fee and incentive fee effective January 1, 2027, and declared Q4 2026 distributions.
Net investment income was $40.3 million, or $0.48 per share, versus $38.2 million, or $0.45 per share, in the quarter ended June 30, 2026.
Earnings per share were $(0.32) versus $0.09 in the prior quarter; net realized losses were $38.2 million and net unrealized depreciation was $29.4 million in the quarter.
Total investment income was $86.1 million, down from $88.8 million, and net asset value per share was $18.76, down from $19.50.
Effective January 1, 2027, the base management fee falls from 1.00% to 0.75% and the incentive fee rate falls from 17.5% to 15.0%; declared Q4 2026 distributions are $0.45 regular and $0.015 supplemental per share.
Xcel Energy issued $2.5 billion of 2.625% convertible senior notes due December 15, 2027, including $300 million from the initial purchasers' option. The notes are convertible into Xcel common stock at an initial conversion price of about $87.26 per share, and conversions can be settled in cash, shares, or a mix. Because the notes are convertible, they could add up to 31,513,750 shares of common stock to the share count if holders convert at the maximum rate.
Issued $2,500,000,000 of 2.625% Convertible Senior Notes due December 15, 2027, dated November 5, 2026
Initial conversion rate of 11.4596 shares per $1,000 principal, or about $87.26 per share
Up to 31,513,750 shares may be issued on conversion at the initial maximum conversion rate of 12.6055 shares per $1,000
Notes cannot be redeemed by Xcel Energy before maturity and carry no sinking fund
Clarus reported third-quarter 2026 sales of $71.2 million, up 2.7% from $69.3 million a year earlier, and net income of $3.3 million ($0.09 per diluted share) versus a net loss of $1.6 million. The company raised its fiscal 2026 sales outlook to $251 million to $255 million and its adjusted EBITDA outlook to about $15 million to $17 million, while cash fell to $20.8 million and the strategic review of alternatives, including a possible sale of the business, continues with no set timetable.
Q3 2026 net income was $3.3 million, or $0.09 per diluted share, compared with a net loss of $1.6 million, or $(0.04), in Q3 2025.
Q3 2026 adjusted EBITDA was $6.8 million (9.6% margin), compared with $1.8 million (2.6% margin) a year earlier; the filing notes a benefit of about $0.6 million from IEEPA tariff refunds.
Full-year 2026 sales outlook is $251 million to $255 million, up from the prior $245 million to $255 million; free cash flow is now expected to be break even, versus a prior outlook of $6 million.
Cash and cash equivalents were $20.8 million at September 30, 2026, down from $36.7 million at December 31, 2025; the company reports no debt.
Neighborhood Intelligence reported third quarter 2026 revenue of $509 million, up 98% year over year, mainly from the acquisitions of Kirkland's and The Container Store. The company also posted a net loss of $26 million, compared with $5 million a year earlier, and gave a 2027 outlook of $2.0 billion to $2.1 billion in consolidated revenue. Revenue growth came from acquisitions, while the larger loss and negative adjusted EBITDA show the company has not yet reached profitability.
Q3 2026 net revenue was $509 million, up from $257 million, with $229 million of the increase from acquired businesses.
Net loss was $26 million, or $0.28 per share, compared with $5 million, or $0.07 per share, a year earlier.
Adjusted EBITDA was negative $26 million, compared with negative $5 million in the prior-year period.
The company expects 2027 consolidated revenue of $2.0 billion to $2.1 billion and gross margins of 33% to 34%.
Orion Properties reported third quarter 2026 revenue of $35.4 million, down from $37.1 million a year earlier, while Core FFO rose to $11.4 million, or $0.20 per diluted share, from $11.0 million, or $0.19. The company raised its 2026 Core FFO per share guidance to $0.75 to $0.78 from $0.72 to $0.77, and says its strategic options review is still ongoing with no assurance of a particular outcome.
Q3 2026 total revenues were $35.4 million, compared with $37.1 million in Q3 2025.
Q3 2026 net loss attributable to common stockholders was $(3.3) million, or $(0.06) per share, compared with $(69.0) million, or $(1.23) per share, in Q3 2025.
2026 Core FFO per share guidance raised to $0.75 to $0.78; net debt to adjusted EBITDA guidance improved to 5.8x to 6.4x.
Board declared a $0.02 per share dividend for Q4 2026, payable January 15, 2027.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.